Does SECUKINUMAB Cause Beta haemolytic streptococcal infection? 24 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 24 reports of Beta haemolytic streptococcal infection have been filed in association with SECUKINUMAB (COSENTYX). This represents 0.0% of all adverse event reports for SECUKINUMAB.
24
Reports of Beta haemolytic streptococcal infection with SECUKINUMAB
0.0%
of all SECUKINUMAB reports
3
Deaths
14
Hospitalizations
How Dangerous Is Beta haemolytic streptococcal infection From SECUKINUMAB?
Of the 24 reports, 3 (12.5%) resulted in death, 14 (58.3%) required hospitalization, and 3 (12.5%) were considered life-threatening.
Is Beta haemolytic streptococcal infection Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 24 reports have been filed with the FAERS database.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Beta haemolytic streptococcal infection?
IBUPROFEN (61)
INFLIXIMAB (58)
ADALIMUMAB (53)
ACETAMINOPHEN (40)
ETANERCEPT (35)
PREDNISOLONE (34)
PREDNISONE (27)
METRONIDAZOLE (26)
RITUXIMAB (26)
METHOTREXATE (25)
Which SECUKINUMAB Alternatives Have Lower Beta haemolytic streptococcal infection Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG